L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 24,000 shares at $20.94 ($503K) on 2016-12-28, disclosed to the SEC on 2016-12-30.
Open-market sale of $503k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.94 | 12,000 | $251K | 50.0% |
| 2 | $20.94 | 12,000 | $251K | 50.0% |
| Total | $20.94 avg | 24,000 | $503K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |